Sfoglia per Autore ABBATE, MARIA IDA
Mostrati risultati da 1 a 8 di 8
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer
2024 Cordani, N; Nova, D; Sala, L; Abbate, M; Colonese, F; Cortinovis, D; Canova, S
Newest therapeutic strategies impacting on rarest thoracic malignancies: The clinical case report of biphasic pleural mesothelioma
2024 Pellicioli, F; Sala, L; Colonese, F; Belloni, E; Abbate, M; Canova, S; D'Agostino, A; Cortinovis, D
Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?
2024 Pagliari, G; Colonese, F; Canova, S; Abbate, M; Sala, L; Petrella, F; Clementi, T; Cortinovis, D
Novel Therapeutic Options for Small Cell Lung Cancer
2023 Canova, S; Trevisan, B; Abbate, M; Colonese, F; Sala, L; Baggi, A; Bianchi, S; D'Agostino, A; Cortinovis, D
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature
2022 Gemelli, M; Carbone, M; Abbate, M; Mancin, M; Zucchini, N; Colonese, F; Invernizzi, P; Bidoli, P; Cortinovis, D
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons
2022 Cortinovis, D; Colonese, F; Abbate, M; Sala, L; Meazza Prina, M; Cordani, N; Sala, E; Canova, S
A new race against lung cancer
2017 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Bidoli, P
Focus on nivolumab in NSCLC
2016 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Bidoli, P
Mostrati risultati da 1 a 8 di 8
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile